Journal of the American Academy of Dermatology
Volume 58, Issue 4 , Pages 625-631 , April 2008

Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial

  • Shanu Kohli Kurd, MHS

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Nana Smith, MD

      Affiliations

    • Department of Dermatology, University of Rochester, Rochester, New York
    • ,
  • Abby VanVoorhees, MD

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Andrea B. Troxel, ScD

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Department of Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Vladimir Badmaev, MD, PhD

      Affiliations

    • Sabinsa Corporation, Piscataway, New Jersey
    • ,
  • John T. Seykora, MD, PhD

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Joel M. Gelfand, MD, MSCE

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence to: Joel M. Gelfand, MD, MSCE, University of Pennsylvania School of Medicine, 2 Maloney Bldg, 3600 Spruce St, Philadelphia, PA 19104.

,Accepted 20 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by departmental funds from the Hospital of the University of Pennsylvania Department of Dermatology, National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal Skin Diseases grant K23AR051125 (Dr Gelfand), NIH/National Center for Complementary and Alternative Medicine Ruth L. Kirschstein National Research Service Award T32-AT00600 (Dr Smith), matching funds University of Pennsylvania School of Medicine (Dr Smith), NIH K30 Center for Clinical Epidemiology and Biostatistics institutional funds (Dr Smith), contributions from various pharmaceutical manufacturers to the pharmacoepidemiology training program at the Center for Clinical Epidemiology and Biostatistics of the University of Pennsylvania (Ms Kurd), the Doris Duke Charitable Foundation (Ms Kurd), and the Clinical and Translational Research Center (Research Grant UL1RR024134 from the National Center For Research Resources) at the University of Pennsylvania. Study drug was provided by the Sabinsa Corp.

 Disclosure: Dr Gelfand has received grant support from Biogenidec, Amgen, Astellas, and Centocor. He has been a consultant for Genentech, Novartis, Warner-Chilcott, Amgen, Centocor, and Wyeth. Ms Kurd is supported by contributions from various pharmaceutical manufacturers to the pharmacoepidemiology training program at the Center for Clinical Epidemiology and Biostatistics of the University of Pennsylvania and the Doris Duke Charitable Foundation. Dr Badmaev is an employee of Sabinsa Corp. Dr VanVoorhees has received grant support from Amgen, Astellas, and Genentech and has been a consultant for Abbott, Amgen, Centocor, Genentech, and Warner-Chilcott. Dr Troxel has received grant support from Aetna and Centocor. Drs Smith and Seykora have no conflicts of interest to declare.

 Reprints not available from the authors.

PII: S0190-9622(08)00004-2

doi: 10.1016/j.jaad.2007.12.035

Journal of the American Academy of Dermatology
Volume 58, Issue 4 , Pages 625-631 , April 2008

Article Tools

* Image Usage & Resolution